mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
0.04 |
0.8 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.0071 |
0.8 |